HIKAL
|
The Current P/B Ratio of HIKAL is 2.04.
| Share Price | ₹208.4 | May 14,2026 |
| Market Cap | ₹2,569.6 Cr | |
| Book Value | ₹1,262.3 Cr | Mar2025 - Consolidated Results |
| Price/Book | 2.04x | Calculated as MarketCap/Book Value |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of HIKAL
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹2,569.6 Cr] as on May 14,2026
(/) Book Value [ ₹1,262.3 Cr] based on Mar2025 - Consolidated Results
(=) P/B Ratio [ 2.04x ]
Thus, for HIKAL , the investors are currently willing to pay '2.04 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of HIKAL !
The chart below summarizes the trend in P/B Ratio of HIKAL over the last five years.
Historical PB (Price/Book ) ratio chart of HIKAL
PB Ratio Performance Analysis for HIKAL
- HIKAL 's p/b ratio for fiscal years ending Mar2025 to Mar2021 averaged 3.26x.
- HIKAL 's operated at median p/b ratio of 3.07x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, HIKAL 's p/b ratio peaked in Mar2022 at 4.65x.
- HIKAL 's p/b ratio hit its five-year low in Mar2021 of 1.9x.
How does HIKAL 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
|---|---|---|---|
| HIKAL | 1,262.30 | 2.04 | 2,569.6 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 72,218.00 | 6.19 | 447,032.0 |
| DIVIS LABORATORIES LTD | 14,969.00 | 12.28 | 183,759.0 |
| CIPLA LTD | 34,431.90 | 3.38 | 116,214.0 |
| TORRENT PHARMACEUTICALS LTD | 7,590.69 | 19.66 | 149,224.0 |
| DR REDDYS LABORATORIES LTD | 37,891.50 | 2.87 | 108,739.0 |
| MANKIND PHARMA LTD | 14,288.70 | 7.11 | 101,634.0 |
| ZYDUS LIFESCIENCES LTD | 23,953.10 | 4.16 | 99,748.0 |
| LUPIN LTD | 22,448.30 | 4.60 | 103,230.0 |
| AUROBINDO PHARMA LTD | 32,653.30 | 2.69 | 87,680.7 |
| ABBOTT INDIA LTD | 4,774.19 | 12.25 | 58,468.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs HIKAL 's P/B Ratio
| Top 10 Industry Peers | PB Ratio |
|---|---|
| Min industry PB | 2.04x |
| Max industry PB | 19.66x |
| Median industry PB | 4.60x |
| Average industry PB | 7.02x |
You may also like the below Video Courses